Previous studies have shown that RIPK2 might be responsible for the chronic inflammation of inflammatory bowel disease (IBD) [28, 29], and the high level of RIPK2 expression was associated with advanced tumors and metastasis of inflammatory breast cancer [30]. The gene discussed is RIPK2; the disease is inflammatory bowel disease.